It is possible that NF-kB depletion might result in inadequate surveillance against noxious agents and cancer [68], but further elucidation of the safety consequences of rapamycin PFC nanoparticles in reducing splenic CD4+Foxp3+ cells might be prudent. This evidence concerns the gene NFKB1 and cancer.